Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 12:36 AM
Ignite Modification Date:
2025-12-25 @ 12:36 AM
NCT ID:
NCT01447667
Eligibility Criteria:
Inclusion Criteria:
* Diagnosed as single hypervascular hepatocellular carcinoma initially
* AJCC stage I HCC
* Child-Pugh class A
* Planning radiofrequency ablation for HCC
* Voluntary agreement for this study
Exclusion Criteria:
* Decreased kidney function (GFR \< 70 mL/min/kg)
* Contraindication to MRI (pacemaker, defibrillator)
* Contrast media hypersensitivity
* Other primary malignancy
* Acute viral hepatitis
* Prior history of liver transplantation
* Thrombosis in splenic vein or portal vein
* Patients who were enrolled to other clinical trials within 4 weeks
* Other severe chronic disease or psychiatric disease
* Pregnant or milk-feeding women
* Patients with coagulopathy, high risk of bleeding for the liver biopsy
* Patients who disagree to participate in this study
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Maximum Age:
80 Years
Study:
NCT01447667
Study Brief:
Protocol Section:
NCT01447667